Awakening guardian angels: drugging the p53 pathway
Currently, around 11 million people are living with a tumour that contains an inactivating
mutation of TP53 (the human gene that encodes p53) and another 11 million have tumours …
mutation of TP53 (the human gene that encodes p53) and another 11 million have tumours …
The role of MDM2 amplification and overexpression in tumorigenesis
JD Oliner, AY Saiki… - Cold Spring …, 2016 - perspectivesinmedicine.cshlp.org
Mouse double minute 2 (MDM2) is a critical negative regulator of the tumor suppressor p53,
playing a key role in controlling its transcriptional activity, protein stability, and nuclear …
playing a key role in controlling its transcriptional activity, protein stability, and nuclear …
The Mdm2–p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor
JJ Manfredi - Genes & development, 2010 - genesdev.cshlp.org
Mdm2 has been well characterized as a negative regulator of the tumor suppressor p53.
Recent studies have shown that Mdm2 is activated in response to a variety of oncogenic …
Recent studies have shown that Mdm2 is activated in response to a variety of oncogenic …
Li–Fraumeni syndrome
D Malkin - Adrenocortical Carcinoma: Basic Science and Clinical …, 2010 - Springer
In 1969, a remarkable cancer predisposition syndrome was reported by Li and Fraumeni.
Using a classical epidemiologic approach, they retrospectively evaluated 280 medical …
Using a classical epidemiologic approach, they retrospectively evaluated 280 medical …
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner
The importance of the p53 stress response pathway in the suppression of tumor formation is
well documented. In a previous report, a single nucleotide polymorphism (SNP309 T/G) was …
well documented. In a previous report, a single nucleotide polymorphism (SNP309 T/G) was …
Attenuating the p53 pathway in human cancers: many means to the same end
AR Wasylishen, G Lozano - Cold Spring …, 2016 - perspectivesinmedicine.cshlp.org
The p53 pathway is perturbed in the majority of human cancers. Although this most
frequently occurs through the direct mutation or deletion of p53 itself, there are a number of …
frequently occurs through the direct mutation or deletion of p53 itself, there are a number of …
Grid'5000: A large scale and highly reconfigurable grid experimental testbed
F Cappello, E Caron, M Dayde… - The 6th IEEE/ACM …, 2005 - ieeexplore.ieee.org
Large scale distributed systems like Grids are difficult to study only from theoretical models
and simulators. Most Grids deployed at large scale are production platforms that are …
and simulators. Most Grids deployed at large scale are production platforms that are …
Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer
J Zhang, Y Jiang, Z Jia, Q Li, W Gong, L Wang… - Clinical & experimental …, 2006 - Springer
Abstract Glucose-regulated protein 78 (GRP78) has been implicated in the protection of
tumor cells from cytotoxic damage and apoptosis and thus assists cells in survival under …
tumor cells from cytotoxic damage and apoptosis and thus assists cells in survival under …
[HTML][HTML] p53 and disease: when the guardian angel fails
JA Royds, B Iacopetta - Cell Death & Differentiation, 2006 - nature.com
The p53 tumor suppressor gene (TP53) is mutated more often in human cancers than any
other gene yet reported. Of importance, it is mutated frequently in the common human …
other gene yet reported. Of importance, it is mutated frequently in the common human …
Excessive genomic DNA copy number variation in the Li–Fraumeni cancer predisposition syndrome
A Shlien, U Tabori, CR Marshall… - Proceedings of the …, 2008 - National Acad Sciences
DNA copy number variations (CNVs) are a significant and ubiquitous source of inherited
human genetic variation. However, the importance of CNVs to cancer susceptibility and …
human genetic variation. However, the importance of CNVs to cancer susceptibility and …